A multicenter study of short- and long-term outcomes in operable pancreatic cancer
Not Applicable
Recruiting
- Conditions
- Pancreatic cancer
- Registration Number
- JPRN-UMIN000049664
- Lead Sponsor
- Department of Gastroenterological surgery 2, Hokkaido University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 2650
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who do not meet the above inclusion criteria 2. Patients with insufficient clinical data 3. Patients deemed inappropriate as research subjects by the principal investigator
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Study 1: To examine biological Borderline Resectable (BR) patients in anatomical Resectable (R) patients of pancreatic cancer Study 2: Effect of changes in CA19-9 levels after preoperative treatment on recurrence and survival Study 3: Evaluation of the Usefulness of serum DUPAN-2 for CA19-9 Non-secretors with Pancreatic Cancer Study 4: An Exploratory study of optimal preoperative treatment for patients with borderline resectable (BR-A) pancreatic cancer Study 5: An Exploratory study of Risk Factors for Perioperative Complications related to Preoperative Therapy Study 6: Analysis of the significance of reticular pattern around superior mesenteric artery in computed tomography of R/BR pancreatic cancer and the effect of preoperative Therapy Study 7: Relationship between ABO blood type and survival outcome after pancreatectomy for pancreatic cancer Study 8: Significance of metastasectomy in patients with recurrent pancreatic cancer after pancreatectomy
- Secondary Outcome Measures
Name Time Method